Barr raises Pliva offer; Cephalon’s Fentora close to approval; Ketek gets a warning.
|
Roche puts brakes on Avastin trial; Barr buys PLIVA for $2.2B; Cyberonics gets a subpoena.
|
Europe’s biggest pharma company adds to its antibiotic program by buying Pliva.
|